Minouk J Schoemaker

researcher

Born 2000-01-01

Minouk J Schoemaker is …
instance of (P31):
humanQ5

External links are
P6178Dimensions author ID01331623740.48
P496ORCID iD0000-0001-8403-2234
P2038ResearchGate profile IDMinouk-Schoemaker
P2002X usernameminouk_schoe

P27country of citizenshipKingdom of the NetherlandsQ29999
P106occupationresearcherQ1650915
P5008on focus list of Wikimedia projectgender gap on Dutch WikipediaQ60687720
P21sex or genderfemaleQ6581072

Reverse relations

author (P50)
Q3587156719p13.1 is a triple-negative-specific breast cancer susceptibility locus
Q371698739q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium
Q93025301A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases
Q43072092A comprehensive study of the association between the EGFR and ERBB2 genes and glioma risk
Q36682471A genome-wide association study of early menopause and the combined impact of identified variants
Q37619303A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium
Q37524853A novel approach to exploring potential interactions among single-nucleotide polymorphisms of inflammation genes in gliomagenesis: an exploratory case-only study
Q89506041Adult weight change and premenopausal breast cancer risk: A prospective pooled analysis of data from 628,463 women
Q34655215Allergic conditions and brain tumor risk
Q48185601Allergy and glioma risk: test of association by genotype.
Q48235089An international case-control study of glutathione transferase and functionally related polymorphisms and risk of primary adult brain tumors
Q43412423An international case-control study of interleukin-4Ralpha, interleukin-13, and cyclooxygenase-2 polymorphisms and glioblastoma risk
Q45979098Association analysis identifies 65 new breast cancer risk loci.
Q56089359Association of Body Mass Index and Age With Subsequent Breast Cancer Risk in Premenopausal Women
Q37268494Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry
Q38914005BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer
Q37002955BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers
Q43581448Body mass index, exercise, and other lifestyle factors in relation to age at natural menopause: analyses from the breakthrough generations study
Q91002126Brain and Salivary Gland Tumors and Mobile Phone Use: Evaluating the Evidence from Various Epidemiological Study Designs
Q62583499Breast Cancer Risk After Recent Childbirth
Q62583508Breast cancer risk in relation to history of preeclampsia and hyperemesis gravidarum: Prospective analysis in the Generations Study
Q64074174Breast cancer risk prediction in women aged 35-50 years: impact of including sex hormone concentrations in the Gail model
Q46088775Breast density measurements with ultrasound tomography: a comparison with non-contrast MRI.
Q57319691CASP8 D302H and meningioma risk: An analysis of five case-control series
Q44288178CYP3A variation, premenopausal estrone levels, and breast cancer risk
Q34560206Cancer incidence and mortality in men with Klinefelter syndrome: a cohort study
Q28269115Cancer incidence in women with Turner syndrome in Great Britain: a national cohort study
Q36740675Cancer risk in patients with constitutional chromosome deletions: a nationwide British cohort study
Q50999553Changes in estradiol and testosterone levels in postmenopausal women after changes in body mass index.
Q37630918Childhood body size and pubertal timing in relation to adult mammographic density phenotype
Q28943530Chromosome 7p11.2 (EGFR) variation influences glioma risk
Q56089366Circulating Vitamin D and Colorectal Cancer Risk: An International Pooling Project of 17 Cohorts
Q48283361Circulating anti-Müllerian hormone and breast cancer risk: A study in ten prospective cohorts
Q94486442Combined associations of a polygenic risk score and classical risk factors with breast cancer risk
Q37681743Combined effects of endogenous sex hormone levels and mammographic density on postmenopausal breast cancer risk: results from the Breakthrough Generations Study
Q34399372Common genetic variants are significant risk factors for early menopause: results from the Breakthrough Generations Study
Q34379032Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium
Q115209587Common variants in breast cancer risk loci predispose to distinct tumor subtypes
Q28943376Common variation at 10p12.31 near MLLT10 influences meningioma risk
Q92528444Comparative Validation of Breast Cancer Risk Prediction Models and Projections for Future Risk Stratification
Q62583503Comparative validation of breast cancer risk prediction models and projections for future risk stratification
Q31082788Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)
Q57319766Comprehensive Analysis of DNA Repair Gene Variants and Risk of Meningioma
Q55467579Comprehensive analysis of the role of DNA repair gene polymorphisms on risk of glioma.
Q89662330Correction to: Timing of pubertal stages and breast cancer risk: the Breakthrough Generations Study
Q57278898Correction: Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)
Q97548420DNA methylation of the long intergenic noncoding RNA 299 gene in triple-negative breast cancer: results from a prospective study
Q37685729DNA mismatch repair gene MSH6 implicated in determining age at natural menopause
Q24633288Determinants of age at menarche in the UK: analyses from the Breakthrough Generations Study
Q47642032Domestic light at night and breast cancer risk: a prospective analysis of 105 000 UK women in the Generations Study
Q55110745E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association Consortium.
Q64078095Epigenome-wide association study for lifetime estrogen exposure identifies an epigenetic signature associated with breast cancer risk
Q51766497Etiology of hormone receptor positive breast cancer differs by levels of histologic grade and proliferation.
Q35064451Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation
Q37342144Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation
Q62583502Exposure to loud noise and risk of vestibular schwannoma: results from the INTERPHONE international case‒control study
Q42596418Familial concordance for age at menarche: analyses from the Breakthrough Generations Study
Q42598119Familial concordance for age at natural menopause: results from the Breakthrough Generations Study
Q44611248Familial concordance for height and its components: analyses from the Breakthrough Generations Study
Q38746332Family history and risk of breast cancer: an analysis accounting for family structure
Q35524465Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2.
Q61230414Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes
Q92480972Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes
Q37367871Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1.
Q114182808Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element
Q46593237Functional polymorphisms in folate metabolism genes influence the risk of meningioma and glioma
Q36742577Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers
Q40137431Gene-environment interactions involving functional variants: Results from the Breast Cancer Association Consortium
Q37739048Genetic modifiers of CHEK2*1100delC-associated breast cancer risk
Q29417068Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome-wide interaction study
Q35925620Genetic predisposition to ductal carcinoma in situ of the breast
Q35151684Genetic predisposition to in situ and invasive lobular carcinoma of the breast
Q35179897Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study
Q48345170Genetic variation in p53 and ATM haplotypes and risk of glioma and meningioma
Q28388497Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types
Q36842233Genome-wide association analysis identifies three new breast cancer susceptibility loci
Q35996692Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer
Q95329367Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses
Q29614921Genome-wide association study identifies five susceptibility loci for glioma
Q36145972Genome-wide association study identifies multiple susceptibility loci for glioma
Q61847493Genome-wide association study of anti-Müllerian hormone levels in pre-menopausal women of late reproductive age and relationship with genetic determinants of reproductive lifespan
Q64040390Genome-wide association study of germline variants and breast cancer-specific mortality
Q38873936Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors
Q114182677Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis
Q37121271High-throughput automated scoring of Ki67 in breast cancer tissue microarrays from the Breast Cancer Association Consortium
Q34593492History of allergic disease and risk of meningioma
Q40475089History of allergies and risk of glioma in adults.
Q30252854Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer
Q36086247Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus
Q46103372Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer
Q52655627Impact of atopy on risk of glioma: a Mendelian randomisation study.
Q114184688Incorporating progesterone receptor expression into the PREDICT breast prognostic model
Q35104068Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer
Q28383820Inherited variation in immune genes and pathways and glioblastoma risk
Q40358881Interaction between 5 genetic variants and allergy in glioma risk
Q34898735Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors
Q57191573Large-Scale Genomic Analyses Link Reproductive Aging to Hypothalamic Signaling, Breast Cancer Susceptibility, and BRCA1-Mediated DNA Repair
Q28267893Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair
Q37265393Length of FMR1 repeat alleles within the normal range does not substantially affect the risk of early menopause
Q55463059Location of gliomas in relation to mobile telephone use: a case-case and case-specular analysis.
Q36896094Low penetrance susceptibility to glioma is caused by the TP53 variant rs78378222.
Q43543604Lung cancer after Hodgkin's disease: a nested case-control study of the relation to treatment
Q45920724MNS16A minisatellite genotypes in relation to risk of glioma and meningioma and to glioblastoma outcome.
Q59830689Medical history, cigarette smoking and risk of acoustic neuroma: An international case-control study
Q114182490Mendelian randomisation study of smoking exposure in relation to breast cancer risk
Q48102990Mendelian randomisation study of the relationship between vitamin D and risk of glioma
Q39855662Meningioma and mobile phone use--a collaborative case-control study in five North European countries
Q37203133Menopausal hormone therapy and breast cancer: what is the true size of the increased risk?
Q24651126Mobile phone use and risk of acoustic neuroma: results of the Interphone case-control study in five North European countries
Q34574151Mobile phone use and risk of glioma in 5 North European countries
Q30500761Mobile phone use and risk of glioma in adults: case-control study
Q90391710Mortality and Cancer Incidence in Carriers of Balanced Robertsonian Translocations: A National Cohort Study
Q62583498Mortality and cancer incidence in carriers of constitutional t(11;22)(q23;q11) translocations: A prospective study
Q59291498Mortality and cancer incidence in males with Y polysomy in Britain: a cohort study
Q47731327Mortality and cancer incidence in women with extra X chromosomes: a cohort study in Britain
Q59291467Mortality in Women with Turner Syndrome in Great Britain: A National Cohort Study
Q34456794Mortality in patients with Klinefelter syndrome in Britain: a cohort study
Q59291487Mortality risks in patients with constitutional autosomal chromosome deletions in Britain: a cohort study
Q92356825Night shift work and risk of breast cancer in women: the Generations Study cohort
Q30374367No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.
Q35492571Non-fatal work related injuries in a cohort of Brazilian steelworkers.
Q39006292Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study
Q62583133Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes
Q36066735Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression
Q37555606Population-based estimates of the prevalence of FMR1 expansion mutations in women with early menopause and primary ovarian insufficiency
Q36583004Prediction of breast cancer risk based on profiling with common genetic variants
Q38494337Predictors of first nonfatal occupational injury following employment in a Brazilian steelworks
Q37350137Prognostic value of automated KI67 scoring in breast cancer: a centralised evaluation of 8088 patients from 10 study groups
Q37096858Psychological stress, adverse life events and breast cancer incidence: a cohort investigation in 106,000 women in the United Kingdom
Q55508030Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.
Q64277598Publisher Correction: Mendelian randomisation study of the relationship between vitamin D and risk of glioma
Q62583506Reply to 'Comment on 'Domestic light at night and breast cancer risk: a prospective analysis of 105 000 UK women in the Generations Study"
Q93106902Reply to Comment on: "Night shift work and risk of breast cancer in women: the Generations Study cohort"
Q45960581Reply: Mobile phone use and acoustic neuroma in five North European countries.
Q59291360Reproducibility of Estradiol and Testosterone Levels in Postmenopausal Women Over 5 Years: Results From the Breakthrough Generations Study
Q48888372Reproductive factors and risk of meningioma and glioma.
Q57452824Response to 'Comment on 'Domestic light at night and breast cancer risk: a prospective analysis of 105 000 UK women in the Generations Study"
Q62583500Response to ‘Comment on ‘Domestic light at night and breast cancer risk: a prospective analysis of 105 000 UK women in the Generations Study”
Q40390297Risk factors for pituitary tumors: a case-control study
Q39877308Risk of pituitary tumors in cellular phone users: a case-control study
Q28606408Search for new loci and low-frequency variants influencing glioma risk by exome-array analysis
Q59291440Secular trends in age at menarche in women in the UK born 1908-93: results from the Breakthrough Generations Study
Q47870125Sex ratio in the offspring of parents with chronic radiation exposure from nuclear testing in Kazakhstan.
Q47162371Smoking and risk of breast cancer in the Generations Study cohort
Q44903190Temporal stability and determinants of white blood cell DNA methylation in the breakthrough generations study
Q49817640The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity.
Q35263089The Breakthrough Generations Study: design of a long-term UK cohort study to investigate breast cancer aetiology
Q23912478The INTERPHONE study: design, epidemiological methods, and description of the study population
Q38370371The Premenopausal Breast Cancer Collaboration: A Pooling Project of Studies Participating in the National Cancer Institute Cohort Consortium
Q55466741The common D302H variant of CASP8 is associated with risk of glioma.
Q42213216The relationship between obesity and exposure to light at night: cross-sectional analyses of over 100,000 women in the Breakthrough Generations Study
Q37690092Timing of pubertal stages and breast cancer risk: the Breakthrough Generations Study
Q91311927Transcriptome-Wide Association Study Identifies New Candidate Susceptibility Genes for Glioma
Q89961489Transcriptome-wide association study of breast cancer risk by estrogen-receptor status
Q43559084Twinning in the offspring of parents with chronic radiation exposure from nuclear testing in Kazakhstan.
Q92994868Two truncating variants in FANCC and breast cancer risk
Q30356919Ultrasound Tomography Evaluation of Breast Density: A Comparison With Noncontrast Magnetic Resonance Imaging.
Q59291476XRCC1 and XRCC3 variants and risk of glioma and meningioma
Q122925830p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study

Search more.